This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kaufman, M Articles by Norton, J Search for Related Content PubMed PubMed Citation Articles by Kaufman, M Articles by Norton, J Pubmed/NCBI databases Medline Plus Health Information Multiple Sclerosis Social Bookmarking                         What's this?

The significant change for the Timed 25-Foot Walk in the Multiple Sclerosis Functional Composite

MS Center, Carolinas HealthCare System, Charlotte, North Carolina, USA

D Moyer

MS Center, Carolinas HealthCare System, Charlotte, North Carolina, USA

J Norton

Department of Biostatistics, Carolinas Medical Center, Carolinas HealthCare System, Charlotte, North Carolina, USA

The Timed 25-Foot Walk is under evaluation as a clinical tool to follow patients with MS. Several approaches have been taken to define a clinically significant change in this measurement. This study was undertaken to define the range of values expected for the Timed 25-Foot Walk and to correlate prospectively the change in walk-time that occurs during an exacerbation of MS associated with subjective difficulty walking. Five results from this study are emphasized. (1) Patients who were minimally affected by MS frequently walked 25 feet between three and five seconds. (2) the walk-time variability, defined as the ratio of the longest to the shortest walk-time, minus 1, times 100%, for three consecutive trials was generally 20% or less; (3) if the two fastest walk-times obtained in three trials were compared, the walk-time variability was almost always 10% or less; (4) for clinically stable individuals, the walk-times of single trials separated by 12 months or less generally varied less than 20%; and (5) patients who complained of difficulty walking, but who did not have changes otherwise detectable by examination, generally had a prolongation of walk-time. These results suggest that an increase of more than 20% in the Timed 25-Foot Walk may indicate a significant change in gait.

Key Words: timed-walk • T25FW • exacerbation

Multiple Sclerosis, Vol. 6, No. 4, 286-290 (2000)
DOI: 10.1177/135245850000600411


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Rudick, C. Polman, J. Cohen, M. Walton, A. Miller, C Confavreux, F. Lublin, M Hutchinson, P. O'Connor, S. Schwid, et al. Assessing disability progression with the Multiple Sclerosis Functional Composite Multiple Sclerosis, August 1, 2009; 15(8): 984 - 997. [Abstract] [PDF]

				A. C. Lo and E. W. Triche Improving Gait in Multiple Sclerosis Using Robot-Assisted, Body Weight Supported Treadmill Training Neurorehabil Neural Repair, November 1, 2008; 22(6): 661 - 671. [Abstract] [PDF]

				T. Schmitz-Hubsch, P. Giunti, D. A. Stephenson, C. Globas, L. Baliko, F. Sacca, C. Mariotti, M. Rakowicz, S. Szymanski, J. Infante, et al. SCA Functional Index: A useful compound performance measure for spinocerebellar ataxia Neurology, August 12, 2008; 71(7): 486 - 492. [Abstract] [Full Text] [PDF]

				J. Paltamaa, T. Sarasoja, E. Leskinen, J. Wikstrom, and E. Malkia Measuring Deterioration in International Classification of Functioning Domains of People With Multiple Sclerosis Who Are Ambulatory Physical Therapy, February 1, 2008; 88(2): 176 - 190. [Abstract] [Full Text] [PDF]

				V. de Groot, H. Beckerman, B. M. J. Uitdehaag, H. C. W. de Vet, G. J. Lankhorst, C. H. Polman, and L. M. Bouter The usefulness of evaluative outcome measures in patients with multiple sclerosis Brain, October 1, 2006; 129(10): 2648 - 2659. [Abstract] [Full Text] [PDF]

				J J Kragt, F A. van der Linden, J M Nielsen, B M. Uitdehaag, and C H Polman Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis Multiple Sclerosis, September 1, 2006; 12(5): 594 - 598. [Abstract] [PDF]

				A. Romberg, A. Virtanen, J. Ruutiainen, S. Aunola, S.-L. Karppi, M. Vaara, J. Surakka, T. Pohjolainen, and A. Seppanen Effects of a 6-month exercise program on patients with multiple sclerosis: A randomized study Neurology, December 14, 2004; 63(11): 2034 - 2038. [Abstract] [Full Text] [PDF]

				L J White, S C McCoy, V Castellano, G Gutierrez, J E Stevens, G A Walter, and K Vandenborne Resistance training improves strength and functional capacity in persons with multiple sclerosis Multiple Sclerosis, December 1, 2004; 10(6): 668 - 674. [Abstract] [PDF]

				S. R. Schwid, A. D. Goodman, M. P. McDermott, C. F. Bever, and S. D. Cook Quantitative functional measures in MS: What is a reliable change? Neurology, April 23, 2002; 58(8): 1294 - 1296. [Abstract] [Full Text] [PDF]